The preliminary biological evaluation demonstrated the beneficial effect of QTC-4-MeOBnE in preventing cognitive decline, amyloidosis, oxidative stress, up regulation of AChE and GSK3- β of STZ-induced AD mice, without showing hepatic and renal toxicity. This evidence concerns the gene ACHE and amyloidosis.